Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06743308 · ClinicalTrials.gov registry record · NA
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
A NA study of Stage IV Lung Cancer AJCC v8 and Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06743308 is a NA study of Stage IV Lung Cancer AJCC v8 and Lung Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, roughly in line with the 97-participant average among 81 other Stage IV Lung Cancer AJCC v8 trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06743308, a NA study of Stage IV Lung Cancer AJCC v8 and Lung Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares the use of a new screening tool designed to evaluate patients' information needs, preferences, and illness understanding to the usual care to improve illness understanding in patients with lung cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or for which no curative treatment is currently available (incurable). Goal concordant care is a model of care that aligns a patient's medical care with their values, preferences, and goals. Often, patients may not fully understand their illness and prognosis, but this information is important so that they can make fully informed decisions regarding their care that are consistent with their values, preferences, and goals. Completing the Information Needs, Preferences, and Understanding Trial (INPUT) screening tool may allow for more frequent and regular discussions regarding disease status and treatment goals, ultimately resulting in improved patient illness understanding and goal concordant care for patients with metastatic or incurable lung cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06743308
The ClinicalTrials.gov registry entry for NCT06743308 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 97-participant average among 81 other Stage IV Lung Cancer AJCC v8 trials with a reported enrollment target. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stage IV Lung Cancer AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT06743308 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06743308 about?
NCT06743308 is a clinical study titled "Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer". This clinical trial compares the use of a new screening tool designed to evaluate patients' information needs, preferences, and illness understanding to the usual care to improve illness understanding in patients with lung cancer that has spread from where it first started (primary site) to other pl...
What is the current status of trial NCT06743308?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-16. Estimated completion is 2027-12-31.
What conditions does trial NCT06743308 study?
This clinical trial studies the following conditions: Stage IV Lung Cancer AJCC v8, Lung Carcinoma, Metastatic Lung Carcinoma.
What interventions are being tested in trial NCT06743308?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER).
Who is sponsoring clinical trial NCT06743308?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06743308 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Lung Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
RECRUITING · NA
-
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
RECRUITING · NA
-
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
RECRUITING · NA
-
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
RECRUITING · NA
-
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
ACTIVE NOT RECRUITING · NA
-
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.